The University of Chicago spinout said that it will use the money to support the commercialization of its saliva-based sequencing test for oral cancers.

A promising new treatment to combat "undruggable" cancers has been green-lit for a human trial in 2025. It's hoped the novel ...

Regulatory authorities issued precautionary recommendations following the ORAL Surveillance trial, which demonstrated an ...

Gentle on aging skin and powerful on persistent breakouts, this new pharmaceutical option is perfect for women battling ...

Approval was based on results from the Phase II TRUST-I and TRUST-II trials, which demonstrated confirmed overall response rates of up to 90% in patients treated with Ibtrozi for locally advanced or ...

Golidocitinib demonstrated promising efficacy in maintaining and enhancing tumor response in peripheral T-cell lymphoma (PTCL ...

Many people are aware of the link between human papillomavirus (HPV) and cervical cancer, but did you know HPV can also cause ...

To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of ...

In the 1950s, a Chinese American physician refused to get with the program at the National Cancer Institute, and ultimately ...

Discover the top 5 cancers affecting Indian men. Learn key symptoms, causes, and prevention tips to catch them early and improve survival rates.

Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2 ...

Mumbai: Glenmark Pharmaceuticals has announced the upcoming launch of the oral blood cancer treatment Zanubrutinib in India, ...